Skip to content

Prestige Consumer Healthcare PBH Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Cencora logo
CencoraCOR
-$328.37M+2.9%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$8.44M-64.1%
Organon logo
OrganonOGN
$95M+144%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$10.02M+130%
Kenvue logo
KenvueKVUE
$5M+66.7%
Church & Dwight logo
Church & DwightCHD
-$131.3M+7.2%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's change in accrued liabilities?
Prestige Consumer Healthcare (PBH) reported change in accrued liabilities of $2.44M in Q4 2025.
How has Prestige Consumer Healthcare's change in accrued liabilities changed year-over-year?
Prestige Consumer Healthcare's change in accrued liabilities decreased by 35.5% year-over-year, from $3.78M to $2.44M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.